Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | THRB | P10828 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.51 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.41 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.40 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Di(Hydroxyethyl)Ether SCHEMBL28181733 | 0.93 | HTT (0.59) | HTTMEN1KMT2ATHRBMAPT | |
| Triethylene Glycol SCHEMBL28094364 | 0.91 | TSHR (0.63) | HTTMEN1KMT2ATHRBMAPT | |
| SCHEMBL27968085 | 0.91 | TSHR (0.63) | HTTMEN1KMT2ATHRBMAPT | |
| SCHEMBL28165908 | 0.91 | USP2 (0.69) | HTTMEN1KMT2ATHRBMAPT | |
| SCHEMBL28189988 | 0.91 | USP2 (0.69) | HTTMEN1KMT2ATHRBMAPT | |
| SCHEMBL16218012 | 0.91 | USP2 (0.69) | HTTMEN1KMT2ATHRBMAPT | |
| SCHEMBL27280251 | 0.91 | USP2 (0.69) | HTTMEN1KMT2ATHRBMAPT | |
| Glycerin SCHEMBL17668302 | 0.89 | MEN1 (0.77) | HTTMEN1KMT2ATHRBMAPT | |
| SCHEMBL10406329 | 0.87 | USP2 (0.69) | HTTMEN1KMT2ATHRBMAPT | |
| SCHEMBL8585380 | 0.87 | USP2 (0.69) | HTTMEN1KMT2ATHRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220031640-A1 | FORMULATIONS FOR EPIDURAL REPAIR | CLARIDEI LABORATORIES, INC. | 2022-02-03 | — | — | US | disclosed |
| US-11135184-B2 | Formulations for epidermal repair | CLARIDEI LABORATORIES, INC. (US) | 2021-10-05 | — | — | US | disclosed |
| US-20180289642-A1 | FORMULATIONS FOR EPIDERMAL REPAIR | CLARIDEI LABORATORIES, INC. | 2018-10-11 | — | — | US | disclosed |
| US-20170020805-A1 | CORDYCEPS CONTAINING TOPICAL SKIN CARE FORMULATION | NSE PRODUCTS, INC. (US) | 2017-01-26 | — | — | US | disclosed |
| WO-2016197144-A1 | CORDYCEPS CONTAINING TOPICAL SKIN CARE FORMULATION | NSE PRODUCTS, INC. (US) | 2016-12-08 | — | — | WO | disclosed |
| US-20160184245-A1 | FORMULATIONS FOR EPIDERMAL REPAIR | CLARIDEI LABORATORIES, INC. | 2016-06-30 | — | — | US | disclosed |
| EP-2494973-A1 | Topical compositions for the treatment and prevention of skin diseases, in particular radiation dermatitis caused by ionising radiation | Sinerga Group S.r.l. (IT) | 2012-09-05 | — | — | EP | disclosed |
| US-20090317345-A1 | Antiperspirant/Deodorant Gel Composition With Low Pouring Temperature | REVLON CONSUMER PRODUCTS CORPORATION (US) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180289642-A1 | FORMULATIONS FOR EPIDERMAL REPAIR | KRT18, CUTA, DSG1 | HTT 4239/4885MEN1 4525/4885KMT2A 4573/4885 |
| US-20160184245-A1 | FORMULATIONS FOR EPIDERMAL REPAIR | KRT18, CUTA, DSG1 | HTT 4195/4885MEN1 4505/4885KMT2A 4502/4885 |
| US-20090317345-A1 | Antiperspirant/Deodorant Gel Composition With Low Pouring Temperature | DRD4, AASDHPPT, DRD5 | HTT 804/4885MEN1 4342/4885KMT2A 1771/4885 |
| US-20220031640-A1 | FORMULATIONS FOR EPIDURAL REPAIR | CUTA, EPHB1, EPHB2 | HTT 3855/4885MEN1 3465/4885KMT2A 3869/4885 |
| US-11135184-B2 | Formulations for epidermal repair | KRT18, CUTA, DSG1 | HTT 4195/4885MEN1 4505/4885KMT2A 4502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.